Quantum leaps after receiving takeover proposal from Clinigen
Quantum Pharma
84.25p
16:09 30/10/17
0.00%
0.00p
UK pharmaceutical developer Quantum Pharma announced it had received an indicative proposal of a possible offer for the company from Clinigen Group.
Clinigen Group
925.00p
16:39 04/04/22
0.00%
0.00p
Food & Drug Retailers
3,956.27
16:59 26/04/24
1.04%
40.66
FTSE AIM 100
3,637.40
17:14 26/04/24
n/a
n/a
FTSE AIM 50
3,960.47
17:14 26/04/24
n/a
n/a
FTSE AIM All-Share
755.28
17:14 26/04/24
n/a
n/a
Pharmaceuticals & Biotechnology
22,773.26
16:59 26/04/24
0.10%
22.78
The proposal from Clinigen and would be satisfied through a combination of new ordinary shares in its fellow London-listed company and cash.
Quantum's board did emphasise that the proposal was non-binding and is subject to preconditions including the customary due diligence.
It noted a further announcement would be made in due course.
Shares in Quantum had advanced 16.71% to 76.15p as of 1245 BST, while Clinigen was up 1.4% to 1,024p.